Pacira BioSciences' Invested Capital fell 17.43% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 17.43%. This contributed to the annual value of $1.4 billion for FY2024, which is 2.08% down from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Invested Capital is $1.1 billion, which was down 17.51% from $1.3 billion recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Invested Capital peaked at $1.8 billion during Q4 2021, and registered a low of $802.5 million during Q1 2021.
Over the past 3 years, Pacira BioSciences' median Invested Capital value was $1.4 billion (recorded in 2023), while the average stood at $1.3 billion.
In the last 5 years, Pacira BioSciences' Invested Capital soared by 116.63% in 2021 and then decreased by 19.06% in 2023.
Pacira BioSciences' Invested Capital (Quarterly) stood at $1.8 billion in 2021, then declined by 17.71% to $1.5 billion in 2022, then dropped by 4.91% to $1.4 billion in 2023, then dropped by 2.08% to $1.4 billion in 2024, then declined by 17.43% to $1.1 billion in 2025.
Its Invested Capital was $1.1 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.4 billion in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value